RWE Strategy Lead Respiratory (DE)

UCB; Monheim am Rhein; Hybrid; EUR 120,000 - 180,000; Full time

Job summary

UCB is seeking a Real-World Evidence Strategy Lead, Respiratory, to shape global evidence plans across development, regulatory, and market access.

Based in Monheim, Germany, this hybrid role combines scientific leadership with cross-functional collaboration and governance of evidence generation.

You will mentor teams, partner with external researchers, and drive timely insights that support patient outcomes.

Qualifications

• Advanced degree in life sciences, medicine, epidemiology, statistics, or related discipline.
• Eight years of pharmaceutical industry experience, ideally within respiratory medicine or immunology.
• Strong expertise in epidemiology, outcomes research, clinical development, regulation, and market access.
• Experience leading cross-functional teams and stakeholder management.
• Excellent English communication and scientific writing with strong quantitative skills.

Responsibilities

• Develop integrated real-world evidence strategies supporting respiratory assets across their lifecycle.
• Translate stakeholder research questions into impactful data, registry, and evidence-generation plans.
• Lead real-world evidence studies, ensuring quality, governance, timelines, and budget adherence.
• Collaborate across functions to align evidence priorities and resolve competing stakeholder needs.
• Build relationships with external experts, research partners, and healthcare decision-makers.
• Mentor evidence-generation professionals and support capability development across the global function.

Skills

Epidemiology

Outcomes Research

Clinical Development

Regulatory & Market Access

Leadership & Mentoring

Scientific Writing

English Communication

Education

Advanced degree in life sciences, medicine, epidemiology, statistics, or related discipline

Job description

We are looking for a Real-World Evidence Strategy Lead, Respiratory who is strategic, collaborative, and results-driven to join us in our Real-World Evidence team, based in Monheim, Germany. This is a hybrid role requiring 40% weekly onsite presence.

About The Role

You will lead the development and delivery of global real-world evidence strategies for respiratory assets. You will translate key research questions into meaningful evidence plans supporting clinical development, regulatory decisions, market access, safety, and patient outcomes. This strategic role combines scientific expertise, cross-functional leadership, and operational oversight to ensure evidence is relevant, timely, and aligned with the needs of healthcare decision-makers.

Who You’ll Work With

You will be working in a team that collaborates across clinical development, regulatory affairs, safety, market access, health economics, medical teams, and regional patient impact functions. You will also build trusted relationships with external scientific experts, research partners, healthcare professionals, reimbursement authorities, and regulatory agencies. Through indirect leadership and mentoring, you will help strengthen capabilities across the global Real-World Evidence function.

What You’ll Do

• Develop integrated real-world evidence strategies supporting respiratory assets throughout their lifecycle.
• Translate stakeholder research questions into impactful data, registry, and evidence-generation plans.
• Lead real-world evidence studies, ensuring quality, governance, timelines, and budget adherence.
• Collaborate across functions to align evidence priorities and resolve competing stakeholder needs.
• Build relationships with external experts, research partners, and healthcare decision-makers.
• Mentor evidence-generation professionals and support capability development across the global function.

Interested? For this role we're looking for the following education, experience and skills

• Advanced degree in life sciences, medicine, epidemiology, statistics, or a related discipline.
• At least eight years' pharmaceutical industry experience, ideally within respiratory medicine or immunology.
• Strong expertise in epidemiology, outcomes research, clinical development, regulation, and market access.
• Experience developing integrated evidence strategies across multiple internal and external stakeholder groups.
• Proven matrix leadership, influencing, mentoring, and cross-functional collaboration capabilities.
• Excellent English communication and scientific writing skills, with strong quantitative expertise.

Are you ready to 'go beyond' to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!

About Us

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.

Why work with us?

At UCB, we don't just complete tasks, we create value. We aren't afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We 'go beyond' to create value for our patients, and always with a human focus, whether that's on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.

At UCB, we've embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [e-mail]. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.